Close

Emergent BioSolutions (EBS) Tops Q3 EPS by 32c; Says FY16 Outlook Still Postponed

Go back to Emergent BioSolutions (EBS) Tops Q3 EPS by 32c; Says FY16 Outlook Still Postponed
EMERGENT BIOSOLUTIONS, Inc. (NYSE: EBS) Delayed: 2.18 -0.11 (4.8%)
Previous Close $2.29    52 Week High $44.38 
Open $2.27    52 Week Low $24.47 
Day High $2.30    P/E 109.00 
Day Low $2.14    EPS $0.02 
Volume 799,932